METHYLPHENIDATE ER(LA) 30 MG CP

methylphenidate
$2.0778per EA
DEA Schedule CII

Strength

30 mg/1

Manufacturer

Sandoz Inc.

NDC

00781236301

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021284

On Market Since

11/24/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.3%

3M

-10.8%

6M

-20.2%

1Y

-29.0%

3Y

-10.4%

5Y

+75.3%

All

-71.0%